Patent disclosure and venture financing: The impact of the American Inventor's Protection Act on corporate venture capital investments

DOIhttp://doi.org/10.1002/sej.1366
Date01 March 2021
AuthorPooyan Khashabi,Ali Mohammadi
Published date01 March 2021
RESEARCH ARTICLE
Patent disclosure and venture financing: The
impact of the American Inventor's Protection Act
on corporate venture capital investments
Ali Mohammadi
1
| Pooyan Khashabi
2,3
1
Department of Strategy and Innovation,
Copenhagen Business School, Frederiksberg
2
Institute for Strategy, Technology and
Organization, LMU Munich, Munich, Germany
3
Department of Management, ESSEC
Business School, Cergy Pontoise, France
Correspondence
Ali Mohammadi, Department of Strategy and
Innovation, Copenhagen Business School,
Kilevej 14a, 2000, Frederiksberg, Denmark.
Email: amo.si@cbs.dk
Abstract
Research Summary: We investigate the effects of patent
disclosure on corporate venture capital (CVC) investments
in technology startups. Toward this end, we focus on the
passage of the American Inventor's Protection Act (AIPA),
which mandated public disclosure of patent applications.
Theoretically, technology disclosure enables CVCs to better
evaluate startups and thus, could increase the likelihood of
investment relations. Conversely, such disclosure may
already satisfy the technology-acquisition objectives of
CVCs, reducing CVCs willingness to form an investment
relation after disclosure. Our empirical analysis finds that
patent disclosure through AIPA increased the likelihood of
receiving CVC investments for startupsspecifically in
industries where patents have higher information signifi-
cance. We provide evidence that the observed pattern is
mainly driven by a reduction of information constraints
regarding startups with patent applications.
Managerial Summary: Receiving corporate venture capital
(CVC) funding is an important success factor for technology
startups. Would disclosure of a startup's innovation
increase or decrease its chance of receiving CVC funding?
On the one hand, disclosure by startups would reduce
uncertainty and search costs for CVC investors, which could
increase the chance of CVC funding. On the other hand,
Received: 28 March 2018 Revised: 14 June 2020 Accepted: 29 July 2020 Published on: 29 September 2020
DOI: 10.1002/sej.1366
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use,
distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
© 2020 The Authors. Strategic Entrepreneurship Journal published by John Wiley & Sons Ltd on behalf of Strategic Management
Society.
Strategic Entrepreneurship Journal. 2021;15:7397. wileyonlinelibrary.com/journal/sej 73
such a disclosure would reveal the startups' technology to
the corporations, which would in turn reduce corporate
incentive to use funding as a window to the startup's technol-
ogy. Thus, disclosure could also reduce the chance of CVC
funding of startups. In this paper, we study the above issue
by examining the case of the American Inventor's Protec-
tion Act (AIPA), which mandated public disclosure of patent
applications. Our results suggest that innovation disclosure
significantly improves the likelihood of CVC funding of
startups.
KEYWORDS
American Inventor's Protection Act (AIPA), corporate venture
capital (CVC), disclosure, patent, startup
1|INTRODUCTION
After years of heated debate, in 1999, the US Congress enacted the American Inventor's Protection Act (hereafter
AIPA) as one of the most fundamentally significant changes to the American patent system in this century(Camp-
bell, 2002, p. 6). This legislative change accelerated the public disclosure of technologies featured in patent applica-
tionsto before the patent grant. Eventually, small and independent inventorssuch as technology startups
became the chief opponents of AIPA, arguing that the new law was harmful for them and largely favored large cor-
porations (see, e.g., Ergenzinger, 2006; Modigliani, 1999). Raising concerns about technology stealing and misappro-
priation, 26 Nobel laureates openly opposed the bill, arguing that AIPA would hurt American small inventors and
technology startups (Modigliani, 1999).
The debates around AIPA are part of a more general discussion about the impacts of innovation disclosure on
market outcomes (see Williams, 2017). A recent and growing body of literature has specifically focused on the disclo-
sure effects of AIPA on markets. This literature includes works investigating the effects of disclosure on markets for
technology (Hegde & Luo, 2017) and on capital markets (Beyhaghi, Khashabi, & Mohammadi, 2020; Kogan,
Papanikolaou, Seru, & Stoffman, 2017; Saidi & Žaldokas, 2020). Yet, the effect of AIPAand patent disclosure in
generalon startups and their investment relationship with corporations has not yet been investigated. In this paper,
we focus on the venture financing market and examine how AIPA has influenced the likelihood of corporate venture
capital (CVC) investment in technology startups. The research question is relevant for several reasons. Many high-
tech startups are formed around intangible assets (Graham & Mowery, 2003), and thus intellectual property (IP) dis-
closure reforms are potentially significant events for these entities. In addition, misappropriation concernswhich
are aggravated by public disclosureare key frictions in the venture financing market (Dushnitsky & Lenox, 2005,
2006; Katila, Rosenberger, & Eisenhardt, 2008). Given the special nature of AIPAas a public pre-grant disclosure
shockstudying its effect on the formation of the CVCstartup investment relationship would generate novel
insights for market participants and policy makers.
Prior to AIPA, the United States Patent and Trademark Office (USPTO) published patent applications only
after the patent was successfully granted. AIPA harmonized the US patent system with the rest of the world and
required all patent applications to be laid open for public inspection 18 months after the initial application
dateregardless of the patent's grant situation. Given that the duration of the average patent review in the
USPTO was significantly longer than 18 months (Hegde & Luo, 2017), AIPA effectively disclosed key
74 MOHAMMADI AND KHASHABI

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT